A study of Glimepiride versus Metformin plus Glimepiride with respect to Glycemic control and lipid profile in type II diabetes mellitus patients
Journal Title: MedPulse -International Medical Journal - Year 2016, Vol 3, Issue 1
Abstract
Introduction: Diabetes Mellitus is a very commonly occurring metabolic disorder characterized by hyperglycemia and altered metabolism of lipids, proteins, and carbohydrates which is due to absolute or relative deficiency of insulin or insulin resistance. Aims and Objectives: To Study of Glimepiride versus Metformin plus Glimepiride With Respect to Glycemic Control and Lipid Profile in Type II Diabetes Mellitus Patients. Methodology: The present study was a open label hospital based prospective study undertaken to study effects of two classes of antidiabetic drugs on lipid profile and oxidative stress. The study period was October 2013 to October 2015. The study was approved by the Ethical Committee of the Medical College. The study population was carried out in all patients with both sexes of Diabetes Mellitus at Rural Hospital. A total of 60 patients with Diabetes Mellitus with Simple Random Sampling satisfying inclusion and exclusion criteria were included in the study. The patient clinically diagnosed as type 2 Diabetes Mellitus Group I (N=30): Diagnosed cases of T2DM being treated with hypoglycemic drug Glimepiride alone. Group II (N=30): Diagnosed cases of T2DM being treated with a combination of Glimepiride and Metformin. Data were double entered using Microsoft excel 2007 and analyzed using SPSS version 11. The ANOVA test where applied in the following results whenever necessary. Result: The difference between fasting blood glucose levels in Group 1 (Glimipride) and Group 2 (Metformin + Glimepiride) was statistically significant at 6 months, 12 months and 18 months i.e. p<0.05.the difference between postprandial blood glucose levels and HbA1c in Group 1 (Glimepiride) and Group 2 (Metformin + Glimipride) was statistically significant at 6 months, 12 months and 18 months i.e. p<0.05.the difference between MDA levels in Group 2 (Glimipride) and Group 4 (Metformin + Glimipride) was statistically significant at 6 months, 12 months and 18 months i.e. p<0.05. The difference between total cholesterol, triglycerides, LDL and HDL in Group 1 (Glimipride) and Group 2 (Metformin + Glimipride) was statistically significant at 6 months, 12 months and 18 months i.e. p<0.05. Conclusion: Combination treatment with metformin plus Glimepride was more effective in improving hyperglycemia, oxidative stress and lipid status in type 2 diabetics.
Authors and Affiliations
Keerti B Kulkarni, P R Gade, Muglikar A G, Bhavthankar S S
Keywords
Related Articles
- EP ID EP199119
- DOI -
- Views 103
- Downloads 0
Study of various treatment modalities used in septic abortion
Introduction: Abortion is the termination of pregnancy by any means before the fetus is sufficiently developed to survive. Any type of abortion when completed with infection it is called septic abortion. Septic abortion...
Study of operated patients of laparoscopy cholecystectomy without using energy source
Introduction: Laparoscopic cholecystectomy (LC) is one of the most common surgeries performed by general surgeon. It is gold standard for symptomatic gall stone disease. But still it is not as safe as open surgery. Most...
Prevalence of depressive disorder in patients attending outpatient department of a tertiary care hospital
Background: Depression is one of the most common mental disorders affecting350 millionpeople. Despite its increased prevalence, persons with depression do not seek treatment. This study was conducted to study the prevale...
Prevalence of Herpes Zoster at dermatology and venereal disease inpatient department: A hospital based study
Introduction: Herpes zoster (HZ), commonly known as shingles, is a localized disease characterized by unilateral radicular pain and a vesicular eruption that is generally limited to the dermatome innervated by single spi...
Association of gestational diabetes mellitus with hypothyroidism in primi gravida: A prospective study
Objective: To study if there is any association between gestational diabetes mellitus with hypothyroidism in primi gravida. Methods: Between June 2014 and May 2015, serum thyrotropin (TSH) screening was performed on all...